GlassScriptPhysician profile
Gregory A Parr
NPI 1194765495
$12,349.13
in general payments reported to CMS, 2019-2025
34 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,365 · 2020: $636 · 2021: $1,390 · 2022: $1,501 · 2023: $646 · 2024: $434 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.17 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $6,113.79 | 2019-2024 | Myrbetriq |
| Neotract INC. | $1,693.25 | 2019-2020 | |
| Axonics, INC. | $1,532.43 | 2020-2023 | Axonics |
| Teleflex LLC | $511.04 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $274.72 | 2019-2024 | |
| Palette Life Sciences, INC. | $214.43 | 2022 | |
| Sumitomo Pharma America, INC. | $195.82 | 2023-2025 | Orgovyx, Gemtesa |
| Allergan, INC. | $174.35 | 2019-2021 | |
| Procept Biorobotics Corporation | $174.08 | 2025 | |
| Urovant Sciences INC | $158.59 | 2022 | |
| Abbvie INC. | $150.86 | 2023-2025 | |
| Cook Medical LLC | $147.69 | 2021-2022 | |
| Healthtronics Stone Solutions, LLC | $143.61 | 2019-2021 | |
| Boston Scientific Corporation | $115.01 | 2019-2024 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $94.97 | 2024 | Prolaris |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $72.53 | 2020-2021 | |
| Medtronic, INC. | $71.85 | 2021-2025 | Altaviva |
| Myovant Sciences INC. | $56.44 | 2022 | |
| Olympus America INC. | $47.77 | 2024-2025 | Itind System |
| Tolmar, INC. | $47.14 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $40.08 | 2022 | |
| Rochester Medical Corporation | $39.97 | 2022 | |
| Antares Pharma, INC. | $36.65 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Verity Pharmaceuticals INC. | $30.65 | 2024 | Trelstar |
| Zyla Life Sciences, INC. | $29.87 | 2019-2020 | |
| Civco Medical Instruments | $23.78 | 2025 | |
| Aytu Biopharma, INC. | $22.28 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.12 | 2024 | |
| Progenics Pharmaceuticals, INC. | $21.10 | 2025 | |
| Blue Earth Diagnostics | $19.94 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.32 | 2019 | |
| 180 Medical, INC. | $14.19 | 2019 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Parr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.